Literature DB >> 27559423

Cerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma.

Yi Zhou1, Marc K Rosenblum2, Ahmet Dogan2, Achim A Jungbluth2, April Chiu2.   

Abstract

Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disorders may be seen in patients with angioimmunoblastic T cell lymphoma (AITL). Although both nodal and extranodal sites of involvement have been described, central nervous system involvement by B cell lymphoma following AITL has not previously been documented. We report a first example of such unusual presentation, in which an 80-year-old man developed diffuse large B cell lymphoma (DLBCL) in the cerebellum 4 months after the initial diagnosis of AITL. EBV-encoded RNAs were detected in the DLBCL, suggesting that EBV played a pivotal role in the pathogenesis of high-grade histologic progression of AITL. The patient survived less than 9 months after his initial diagnosis of AITL. We believe that this case expands the spectrum of extranodal manifestation of EBV-positive B cell lymphoma associated with AITL and illustrates the importance of recognition of this association when encountering unusual central nervous system lesions in patients with known AITL.

Entities:  

Keywords:  Angioimmunoblastic Tcell lymphoma; Central nervous system; Diffuse large B cell lymphoma

Year:  2015        PMID: 27559423      PMCID: PMC4993208          DOI: 10.1007/s12308-015-0241-8

Source DB:  PubMed          Journal:  J Hematop        ISSN: 1865-5785            Impact factor:   0.196


  28 in total

1.  Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified.

Authors:  Karen L Grogg; Ayoma D Attygalle; Ayoma D Attygale; William R Macon; Ellen D Remstein; Paul J Kurtin; Ahmet Dogan
Journal:  Mod Pathol       Date:  2006-05-05       Impact factor: 7.842

2.  Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.

Authors:  Nives Dzeko Skugor; Zinaida Perić; Radovan Vrhovac; Delfa Radić-Kristo; Ika Kardum-Skelin; Branimir Jaksić
Journal:  Coll Antropol       Date:  2010-03

3.  Independent growth of diffuse large B cell lymphoma and angioimmunoblastic T cell lymphoma originating from composite lymphoma.

Authors:  Rie Tabata; Chiharu Tabata; Ryoji Yasumizu; Masaru Kojima
Journal:  Ann Hematol       Date:  2014-02-01       Impact factor: 3.673

4.  Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified.

Authors:  Andreas Zettl; Seung-Sok Lee; Thomas Rüdiger; Petr Starostik; Mirella Marino; Thomas Kirchner; Michaela Ott; Hans Konrad Müller-Hermelink; German Ott
Journal:  Am J Clin Pathol       Date:  2002-03       Impact factor: 2.493

5.  Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Am J Med       Date:  1975-12       Impact factor: 4.965

Review 6.  Epstein-Barr virus: 40 years on.

Authors:  Lawrence S Young; Alan B Rickinson
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

7.  Angioimmunoblastic lymphadenopathy. Long-term follow-up study.

Authors:  G A Pangalis; E M Moran; B N Nathwani; R J Zelman; H Kim; H Rappaport
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

Review 8.  Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications.

Authors:  Kieron Dunleavy; Wyndham H Wilson; Elaine S Jaffe
Journal:  Curr Opin Hematol       Date:  2007-07       Impact factor: 3.284

9.  CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma.

Authors:  Ayoma D Attygalle; Timothy C Diss; Philippa Munson; Peter G Isaacson; Ming Q Du; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

Review 10.  Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.

Authors:  Qing-Xu Yang; Xiao-Juan Pei; Xiao-Ying Tian; Yang Li; Zhi Li
Journal:  Diagn Pathol       Date:  2012-01-19       Impact factor: 2.644

View more
  5 in total

1.  Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma.

Authors:  Akiko Hashimoto; Satsuki Asai; Yasuhiro Tanaka; Isaku Shinzato
Journal:  Eur J Case Rep Intern Med       Date:  2021-10-27

2.  Epstein-Barr virus positive diffuse large B-cell lymphoma transformed into angioimmunoblastic T-cell lymphoma after treatment.

Authors:  Chaoyu Wang; Yi Gong; Qingming Jiang; Xiping Liang; Rui Chen
Journal:  Clin Case Rep       Date:  2021-05-05

3.  Promising Response to Lenalidomide-Combination Therapy in a Discordant Lymphoma Consisting of EBV-Positive Diffuse Large B-Cell Lymphoma and Angioimmunoblastic T-Cell Lymphoma: A Case Report.

Authors:  Pan Hu; Yu Ben; Juan Liu; Weicheng Zheng; Xiyue Yan; Yaping Zhang; Wenyu Shi
Journal:  Onco Targets Ther       Date:  2021-04-12       Impact factor: 4.147

4.  Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein-Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma.

Authors:  Fen Zhang; Wenyu Li; Qian Cui; Yu Chen; Yanhui Liu
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

5.  Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma.

Authors:  Taegeun Lee; Borae G Park; Eunkyoung You; Young Uk Cho; Seongsoo Jang; Sun Mi Lee; Cheolwon Suh; Chan Jeoung Park
Journal:  Ann Lab Med       Date:  2018-03       Impact factor: 3.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.